Skip to main content
. 2002 Jan;66(1):19–25.

graphic file with name 4FF4.jpg

Figure 4. Collagenase/gelatinase activity in conditioned media from cartilage explants exposed to recombinant equine interleukin-1β (reIL-1) or recombinant human interleukin-1β (rhIL-1) for 24 h. Treatments: lane 1: control; lane 2: 50 ng/mL rhIL-1β; lane 3: 10 ng/mL reIL-1β; lane 4: 50 ng/mL reIL-1β; lane 5: 100 ng/mL reIL-1β.